Recent Press Releases

Vitamin D + TB Vaccine: Allies in Fight Against Bladder Cancer?

Vitamin D + TB Vaccine: Allies in Fight Against Bladder Cancer? May 21, 2012 The tuberculosis vaccine is often used as a treatment for bladder cancer, and adding vitamin D might improve the vaccine's...

Army study: DNA vaccine and duck eggs protect against hantavirus disease

Army study: DNA vaccine and duck eggs protect against hantavirus disease Public release date: 23-May-2012 Army scientists and industry collaborators have successfully protected laboratory animals...

Flu shot during pregnancy shows unexpected benefits in large study

Flu shot during pregnancy shows unexpected benefits in large study May 22, 2012 Ottawa – Getting a flu shot during pregnancy provides unanticipated benefits to the baby, according to the...

Mucosis announces positive proof-of-concept data for Mimopath® platform in humans

Mucosis announces positive proof-of-concept data for Mimopath® platform in humans Groningen, the Netherlands, May 10, 2012 Dutch vaccine development company Mucosis B.V. today announced Phase I...

Intellect Neurosciences Expands Its Immunotherapy Pipeline with New Technology Platforms Targeting Pathogenic Protein Aggregates Focused on Huntington's and Parkinson's Diseases

Intellect Neurosciences Expands Its Immunotherapy Pipeline with New Technology Platforms Targeting Pathogenic Protein Aggregates Focused on Huntington's and Parkinson's Diseases Company Files...

Brain Cancer vaccine trial - King's College London and King's College Hospital

Brain Cancer vaccine trial - King's College London and King's College Hospital Posted on 14/05/2012 A brain cancer trial that uses a patient's tumour to develop their own personalised...

Vical Updates Herpes Simplex Vaccine Development at ASGCT Conference

Vical Updates Herpes Simplex Vaccine Development at ASGCT Conference 05/16/2012 PHILADELPHIA, May 16, 2012 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that results from...

Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for Advanced Metastatic Melanoma

Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for Advanced Metastatic Melanoma NEWTON, Mass.--(BUSINESS WIRE)--May. 15, 2012-- Galectin Therapeutics...

Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial

Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial Inovio Synthetic DNA Vaccine Achieves Proof of Principle With...

Biovest Retains Ferghana Partners to Evaluate Strategic Transactions

Biovest Retains Ferghana Partners to Evaluate Strategic Transactions Released: 05/16/12 Biovest International, Inc. (OTCQB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc....

Biovest to Seek Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine

Biovest to Seek Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine Released: 05/14/12 Biovest International, Inc. (OTCQB:BVTI), a majority-owned subsidiary of...

Successfully results from clinical study with Vacc-4x and Endocine

Successfully results from clinical study with Vacc-4x and Endocine Oslo 10.05.2012 - Successful Immunization and Safety Documented in Nasal Administration Study of the HIV Vaccine Vacc-4x together...

UC San Diego Biologists Produce Potential Malarial Vaccine from Algae

UC San Diego Biologists Produce Potential Malarial Vaccine from Algae May 16, 2012 Biologists at the University of California, San Diego have succeeded in engineering algae to produce potential...

Cancer vaccine combination therapy shows survival benefit in breast cancer

Cancer vaccine combination therapy shows survival benefit in breast cancer Studies in mice offer promise of new prevention strategy and treatment May 15, 2012 (SACRAMENTO, Calif.) — A vaccine...

FDA-approved Drug Makes Established Cancer Vaccine Work Better, Penn Study Finds

FDA-approved Drug Makes Established Cancer Vaccine Work Better, Penn Study Finds May 16, 2012 PHILADELPHIA — A team from the Perelman School of Medicine and the Abramson Family Cancer...

Vaccine Aims to Give the Heaves the Heave-Ho

Vaccine Aims to Give the Heaves the Heave-Ho Researchers Test Vaccine Designed to Protect Against Cause of Stomach Flu May 07, 2012 Rochester scientists are looking for 20 people willing to roll up...

Profectus BioSciences, Inc. Receives $5.6M Grant to Develop a Vaccine to Protect Humans against Infection with Nipah/Hendra Viruses

Profectus BioSciences, Inc. Receives $5.6M Grant to Develop a Vaccine to Protect Humans against Infection with Nipah/Hendra Viruses BALTIMORE, May 09, 2012 (BUSINESS WIRE) -- Profectus BioSciences,...

Broad Patent Protection Granted for iBio Immunomodulator

Broad Patent Protection Granted for iBio Immunomodulator NEWARK, Del., May 8, 2012 /PRNewswire via COMTEX/ -- iBio, Inc. today announced issuance of a US patent covering compositions of matter and...

NOVAVAX Launches Additional Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate

NOVAVAX Launches Additional Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate ROCKVILLE, Md., May 9, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it has begun...

Aeras and CanSino Partner on Pre-Clinical Study of TB Vaccine Candidate

Aeras and CanSino Partner on Pre-Clinical Study of TB Vaccine Candidate Tianjin CanSino Biotechnology Inc. (CanSino) and Aeras today announce a collaboration to advance the development of CanSino's...